{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:43:16Z","timestamp":1779882196506,"version":"3.53.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5512-9","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T13:03:47Z","timestamp":1554728627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Masato","family":"Yasui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroji","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8857-9798","authenticated-orcid":false,"given":"Yasuhide","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"5512_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"BF Torre LA","year":"2015","unstructured":"Torre LA BF, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"5512_CR2","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/jjco\/hyv088","volume":"45","author":"HM MT","year":"2015","unstructured":"MT HM, Shibata A, Katanoda K, Sobue T, Nishimoto H. Japan Cancer surveillance research group. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the monitoring of Cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45:884\u201391.","journal-title":"Jpn J Clin Oncol"},{"issue":"12","key":"5512_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/cancers9020020","volume":"9","author":"Peng Li","year":"2017","unstructured":"Li PCJ, Miyamoto H. Androgen receptor signaling in bladder Cancer. Cancers (Basel). 2017;9. https:\/\/doi.org\/10.3390\/cancers9020020 .","journal-title":"Cancers"},{"key":"5512_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/jjco\/hys072","volume":"42","author":"YIK Li","year":"2012","unstructured":"Li YIK, Miyamoto H. The role of the androgen receptor in the development and progression of bladder cancer. Jpn J Clin Oncol. 2012;42:569\u201377.","journal-title":"Jpn J Clin Oncol"},{"key":"5512_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/384860","volume":"2015","author":"Lucien McBeth","year":"2015","unstructured":"McBeth L GM, Selman S, Hinds TD Jr. Involvement of the androgen and glucocorticoid receptors in bladder Cancer. Int J Endocrinol 2015. https:\/\/doi.org\/10.1155\/2015\/384860 .","journal-title":"International Journal of Endocrinology"},{"issue":"4","key":"5512_CR6","first-page":"150","volume":"12","author":"AHAM Rahmani","year":"2013","unstructured":"Rahmani AHAM, Babiker AY, Khan AA, Aly SM, Rizvi MA. Implication of androgen receptor in urinary bladder cancer: a critical mini review. Int J Mol Epidemiol Genet. 2013;12(4):150\u20135.","journal-title":"Int J Mol Epidemiol Genet"},{"key":"5512_CR7","doi-asserted-by":"publisher","first-page":"R265","DOI":"10.1530\/ERC-15-0209","volume":"22","author":"APMM Lombard","year":"2015","unstructured":"Lombard APMM. The emerging role of the androgen receptor in bladder cancer. Endocr Relat Cancer. 2015;22:R265\u201377.","journal-title":"Endocr Relat Cancer"},{"key":"5512_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF00256185","volume":"3","author":"EHT Okajima","year":"1975","unstructured":"Okajima EHT, Iriya K, Ijuin M, Matsushima S. Effects of sex hormones on development of urinary bladder tumours in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Urol Res. 1975;3:73\u20139.","journal-title":"Urol Res"},{"key":"5512_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000292737","volume":"34","author":"SSN Terada","year":"1992","unstructured":"Terada SSN, Uchide K, Akasofu K, Nishida E. Effect of testosterone on the development of bladder tumors and calculi in female rats. Gynecol Obstet Investig. 1992;34:105\u201310.","journal-title":"Gynecol Obstet Investig"},{"key":"5512_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1159\/000474484","volume":"31","author":"SAH Imada","year":"1997","unstructured":"Imada SAH, Ami Y, Koiso K, Ideyama Y, Takenaka T. Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats. Eur Urol. 1997;31:360\u20134.","journal-title":"Eur Urol"},{"issue":"99","key":"5512_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/jnci\/djk113","volume":"4","author":"HYZ Miyamoto","year":"2007","unstructured":"Miyamoto HYZ, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh S, Messing EM, Chang C. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst. 2007;4(99):558\u201368.","journal-title":"J Natl Cancer Inst"},{"key":"5512_CR12","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.ajpath.2013.01.018","volume":"182","author":"JWHI Hsu","year":"2013","unstructured":"Hsu JWHI, Xu D, Miyamoto H, Liang L, Wu XR, Shyr CR, Chang C. Decreased tumorigenesis and mortality from bladder Cancer in mice lacking urothelial androgen receptor. Am J Pathol. 2013;182:1811\u201320.","journal-title":"Am J Pathol"},{"key":"5512_CR13","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3349\/ymj.2014.55.5.1214","volume":"55","author":"JKPS Nam","year":"2014","unstructured":"Nam JKPS, Lee SD, Chung MK. Prognostic value of sex-hormone receptor expression in non-muscle-invasive bladder cancer. Yonsei Med J. 2014;55:1214\u201321.","journal-title":"Yonsei Med J"},{"key":"5512_CR14","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1111\/j.1464-410X.2011.10706.x","volume":"109","author":"HYJ Miyamoto","year":"2012","unstructured":"Miyamoto HYJ, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing EM, Netto GJ, Yeh S. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder. BJU Int. 2012;109:1716\u201326.","journal-title":"BJU Int"},{"key":"5512_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.tranon.2017.01.013","volume":"10","author":"DBJ Sikic","year":"2017","unstructured":"Sikic DBJ, Hartmann A, Burger M, Erben P, Denzinger S, Eckstein M, St\u00f6hr R, Wach S, Wullich B, Keck B, Wirtz RM, Otto W. High androgen receptor mRNA expression is independently associated with prolonged Cancer-specific and recurrence-free survival in stage T1 bladder Cancer. Transl Oncol. 2017;10:340\u20135.","journal-title":"Transl Oncol"},{"key":"5512_CR16","doi-asserted-by":"publisher","first-page":"12665","DOI":"10.18632\/oncotarget.2851","volume":"5","author":"KTM Izumi","year":"2014","unstructured":"Izumi KTM, Miyamoto H, Hara Y, Kishida T, Chiba K, Murai T, Hirai K, Suzuki K, Fujinami K, Ueki T, Udagawa K, Kitami K, Moriyama M, Miyoshi Y, Tsuchiya F, Ikeda I, Kobayashi K, Sato M, Morita S, Noguchi K, Uemura H. Androgen deprivation therapy prevents bladder cancer recurrence. Oncotarget. 2014;5:12665\u201374.","journal-title":"Oncotarget"},{"key":"5512_CR17","doi-asserted-by":"publisher","first-page":"432.e15","DOI":"10.1016\/j.urolonc.2016.05.016","volume":"34","author":"TIH Kawahara","year":"2016","unstructured":"Kawahara TIH, Kashiwagi E, El-Shishtawy KA, Li Y, Reis LO, Zheng Y, Miyamoto H. Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth. Urol Oncol. 2016;34:432.e15\u201323.","journal-title":"Urol Oncol"},{"key":"5512_CR18","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1097\/01.ju.0000092238.15685.10","volume":"170","author":"FLP Chen","year":"2003","unstructured":"Chen FLP, Zhang G, Iwamoto Y, See W. Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines. J Urol. 2003;170:2009\u201313.","journal-title":"J Urol"},{"key":"5512_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051862","volume":"7","author":"KF Budczies J","year":"2012","unstructured":"Budczies J KF, Sinn BV, Gy\u0151rffy B, Schmitt WD, Darb-Esfahani S, Denkert C. Cutoff finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization. PLoS One. 2012;7:e51862.","journal-title":"PLoS One"},{"key":"5512_CR20","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1038\/onc.2013.274","volume":"19","author":"CLS Chang","year":"2014","unstructured":"Chang CLS, Yeh S, Chang TM. Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Oncogene. 2014;19:3225\u201334.","journal-title":"Oncogene"},{"key":"5512_CR21","first-page":"3","volume":"37","author":"RAGM Davey","year":"2016","unstructured":"Davey RAGM. Androgen receptor structure, function and biology: from bench to bedside. Clin Biochem Rev. 2016;37:3\u201315.","journal-title":"Clin Biochem Rev"},{"key":"5512_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S0022-5347(05)66041-7","volume":"166","author":"SSR Salmi","year":"2001","unstructured":"Salmi SSR, Gustafsson JA, M\u00e4kel\u00e4 S. Co-localization of androgen receptor with estrogen receptor beta in the lower urinary tract of the male rat. J Urol. 2001;166:674\u20137.","journal-title":"J Urol"},{"key":"5512_CR23","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.juro.2014.01.012","volume":"191","author":"LMYY Shortliffe","year":"2014","unstructured":"Shortliffe LMYY, Behr B, Wang B. Testosterone changes bladder and kidney structure in juvenile male rats. J Urol. 2014;191:1913\u20139.","journal-title":"J Urol"},{"key":"5512_CR24","doi-asserted-by":"crossref","unstructured":"Inoue SMT, Miyamoto H. Role of the androgen receptor in urothelial cancer. Mol Cell Endocrinol. 2017.","DOI":"10.1016\/j.mce.2017.06.021"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5512-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5512-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5512-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T12:52:09Z","timestamp":1663246329000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5512-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5512"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5512-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"24 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"IRB approval for Yokohama City University. Informed consent was obtained in the form of opt-out on the web-site. Those who rejected were excluded.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"331"}}